Enrofloxacin
SKU: 02199019-CF
Enrofloxacin
Application Notes
Enrofloxacin it is a bactericidal agent. Typically used as an antibiotic against Staphylococcus aureus, Escherichia coli, Salmonella spp., Klebsiella spp., and Pasteurella spp. Has been used as a plant fungicide.
Usage Statement
Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department.
Key Applications
Antibacterial
| SKU | 02199019-CF |
| Alternate Names | 1-Cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-Fluoro-1,4-Dihydro-4-Oxo-3-Quinolonecarboxylic Acid; CFPQ; Bay Vp 2674; Baytril |
| Application Notes | Enrofloxacin it is a bactericidal agent. Typically used as an antibiotic against Staphylococcus aureus, Escherichia coli, Salmonella spp., Klebsiella spp., and Pasteurella spp. Has been used as a plant fungicide. |
| Base Catalog Number | 199019 |
| Beilstein Registry Number | 5307824 |
| CAS # | 93106-60-6 |
| Format | Powder |
| Melting Point | 219-221 deg C |
| Molecular Formula | C19H22FN3O3 |
| Molecular Weight | 359.401 g/mol |
| Personal Protective Equipment | Eyeshields, Gloves, respirator filter |
| Purity | ≥98% (dry basis) |
| RTECS Number | VB1993650 |
| Solubility | >53.9 [ug/mL] |
| Typical Working Concentration | 5-25 µg/mL (average is 10 µg/mL). Enrofloxacin is typically used for approximately 12 to 20 days in cell culture media with the media being changed every 3 to 4 days. Oral adminstration is typically given at 10 mg/kg; IV administration is typically given at 5 mg/kg. |
| Usage Statement | Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department. |